CSPC Innovation Pharmaceutical Co., Ltd. (SZSE:300765) announces a share repurchase program. Under the program, the company will repurchase up to CNY 421.8 million worth of its A shares. The shares will be repurchased at a price not more than CNY 21.09 per share. The repurchased shares will be used for employee stock ownership plans or equity incentive. The repurchases will be funds from company's own funds or self-raised funds. The program will be valid for a period of 12 months.

On October 24, 2023, the company adjusted the maximum repurchase price from not more than CNY 21.09 per share to not more than CNY 26.11 per share.

On February 23, 2024, the company adjusted the maximum repurchase price from not more than CNY 26.11 per share to not more than CNY 38.00 per share.

On April 26, 2024, the company adjusted the maximum repurchase price from not more than CNY 38 per share to not more than CNY 31.41 per share.